Accelerate drug development           Proteomics technology           
   Intrinsic Bioprobes' mission is to improve the diagnosis
   and treatment of disease through the application of
   mass spectrometry based technologies. login
Thermo Fisher Scientific acquires Intrinsic Bioprobes Inc.
Intrinsic Bioprobes launches three new CLIA approved mass spectrometry-based tests for proteins implicated in kidney disease and renal failure.
Intrinsic Bioprobes to present at the AAPS National Biotechnology Conference in San Francisco, May 16-18, 2011.
Selected Reaction Monitoring - Mass Spectrometric Immunoassay Responsive to Parathyroid Hormone and Related Variants

Home | Sitemap | Directions | Literature